Rui Zheng
- Hematology top 1%
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 9
- Genetics top 2%
- Molecular Biology top 10%
- Cancer-related gene regulation 6
- Immunology top 10%
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 6
-
- Respiratory viral infections research 5
-
- Asthma and respiratory diseases 5
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Co-authors
- Donald SmallGerd A. BlobelMark J. LevisBrenda R. BaldwinAlan D. FriedmanBruce RuggeriKam-Fai TseSusan Jones‐Bolin
- Journals
- The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Rui Zheng
123 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 167
- Hematology 847
- Genetics 351
- Health Information Management 79
- Molecular Biology 1.1k
- Immunology 251
Countries citing papers authored by Rui Zheng
This map shows the geographic impact of Rui Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Zheng more than expected).
Fields of papers citing papers by Rui Zheng
This network shows the impact of papers produced by Rui Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Zheng. The network helps show where Rui Zheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2020 | 0 | |
| 12 | 2018 | 9 | |
| 13 | 2018 | 11 | |
| 14 | 2018 | 4 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 3 | |
| 17 | 2016 | 34 | |
| 18 | 2015 | 6 | |
| 19 | 2006 | 161 | |
| 20 | Effect of Src on proliferation and invasion of lung adenocarcinoma A549 cell line | 2005 | 1 |
About Rui Zheng
Rui Zheng is a scholar working on Applied Microbiology and Biotechnology, Complementary and alternative medicine and Infectious Diseases, having authored 131 papers that have together received 2.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Cancer-related gene regulation (6 papers), COVID-19 Clinical Research Studies (6 papers), Respiratory viral infections research (5 papers), Asthma and respiratory diseases (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). The work is most often cited by research in Hematology (847 citations), Genetics (351 citations) and Health Information Management (79 citations). Rui Zheng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Donald Small, Gerd A. Blobel, Mark J. Levis, Brenda R. Baldwin, Alan D. Friedman, Bruce Ruggeri, Kam-Fai Tse, Susan Jones‐Bolin, B. Douglas Smith and Craig A. Dionne. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.